Category: R

Risk Management System (RMS)

A set of pharmacovigilance activities and interventions designed to identify, characterise, prevent or minimise risks relating to medicinal products, including the assessment of the effectiveness

Read More »

Regulatory Authority

The legal authority that is responsible for regulating all matters relating to drugs and medicinal products (e.g.: EMA, FDA, MHRA)

Read More »

Risk Management

Activity that aims to ensure that the benefits of a medicinal product exceed the risks by the greatest achievable margin, by increasing the benefits or

Read More »

Risk

The probability of developing an outcome (refers normally but not always to a negative outcome). Absolute risk or Incidence Rate: The observed or calculated probability of the

Read More »

Rational Drug Use

Therapeutic practice where drugs are prescribed and used appropriately for the indication and the patient’s specific characteristics.

Read More »

Rechallenge

Rechallenge means reintroducing the drug to the patient. A positive rechallenge (the AE reappears) strongly suggests a causal relationship.

Read More »

Recruitment

Active efforts by investigators to identify subjects who may be suitable for enrollment into a clinical trial. Subjects are selected on the basis of the

Read More »

Real World Studies

Real-world studies seek to provide a line of complementary evidence to that provided by randomized controlled trials (RCTs). While RCTs provide evidence of efficacy, real-world

Read More »

Randomized Allocation

A type of allocation strategy in which participants are assigned to the arms of a clinical trial by chance. Source: Clinicaltrials.gov

Read More »

Randomization

The process of assigning trial subjects to investigational treatment or control groups (may use a comparator) using an element of chance to determine the assignments

Read More »

Rolling Submission

[FDA] In a rolling submission (also known as rolling review), a drug company can submit completed sections of its Biologic License Application (BLA) or New

Read More »

Related Sequence

Sequences may be related to one another within one regulatory activity. The related sequence number should always be stated. In case of activities with only

Read More »

Regulatory Intelligence

Act of gathering and analyzing regulatory information and monitoring current regulatory climate and using this data to generate creative and innovative regulatory strategies designed to

Read More »

Regulatory Affairs

The department or function that is responsible for ensuring compliance with government regulations and interacts with the regulatory agencies. Each drug sponsor has a regulatory

Read More »

Regulatory Activity

A public authority or government agency responsible for exercising autonomous authority over some area of human activity in a regulatory or supervisory capacity. An independent

Read More »

Reference Listed Drug

[FDA] The listed drug identified by FDA as the drug product upon which an applicant relies in seeking approval of its abbreviated application. Source: 21

Read More »

Rapporteur

[EMA] One of the two members of a committee or working party who leads the evaluation of an application. Source: EMA Glossary

Read More »